Pharmacological effects of berberine on mood disorders

被引：67

作者：

Fan, Jie ^{[1
]}

Zhang, Kun ^{[1
]}

Jin, Yang ^{[1
]}

Li, Bingjini ^{[1
]}

Gao, Shuohui ^{[2
]}

Zhu, Jiaming ^{[1
]}

Cui, Ranji ^{[1
]}

机构：

[1] Jilin Univ, Jilin Prov Key Lab Mol & Chem Genet, Hosp 2, Changchun, Jilin, Peoples R China

[2] Jilin Univ, Dept Gastrointestinal Colorectal Surg, China Japan Union Hosp, Changchun, Jilin, Peoples R China

来源：

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE | 2019年 / 23卷 / 01期

关键词：

anxiety; berberine; bipolar disorder; depression; mechanism; pharmacology; ACTIVATED PROTEIN-KINASE; NITRIC-OXIDE SYNTHASE; STAR-ASTERISK-D; NF-KAPPA-B; SIGMA-1; RECEPTORS; IN-VITRO; ISOQUINOLINE ALKALOIDS; MAJOR DEPRESSION; PC12; CELLS; RAT MODEL;

D O I：

10.1111/jcmm.13930

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

Berberine, a natural isoquinoline alkaloid, is used in herbal medicine and has recently been shown to have efficacy in the treatment of mood disorders. Furthermore, berberine modulates neurotransmitters and their receptor systems within the central nervous system. However, the detailed mechanisms of its action remain unclear. This review summarizes the pharmacological effects of berberine on mood disorders. Therefore, it may be helpful for potential application in the treatment of mood disorders.

引用

页码：21 / 28

页数：8

共 50 条

[31] Berberine: New Insights from Pharmacological Aspects to Clinical Evidences in the Management of Metabolic Disorders
Caliceti, Cristiana
Franco, Placido
Spinozzi, Silvia
Roda, Aldo
Cicero, Arrigo F. G.
CURRENT MEDICINAL CHEMISTRY, 2016, 23 (14) : 1460 - 1476
[32] PHARMACOLOGICAL INVESTIGATIONS OF BERBERINE SULFATE
KULKARNI, SK
VARANDANI, NL
DANDIYA, PC
JAPANESE JOURNAL OF PHARMACOLOGY, 1972, 22 (01): : 11 - +
[33] Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine
Imanshahidi, Mohsen
Hosseinzadeh, Hossein
PHYTOTHERAPY RESEARCH, 2008, 22 (08) : 999 - 1012
[34] Antisuicidal Effects in Mood Disorders: Are They Unique to Lithium?
Tondo, Leonardo
Baldessarini, Ross J.
PHARMACOPSYCHIATRY, 2018, 51 (05) : 177 - 188
[35] Vortioxetine - pharmacological properties and use in mood disorders. The current state of knowledge
Krupa, Anna Julia
Wojtasik-Bakalarz, Krzysztof
Siwek, Marcin
PSYCHIATRIA POLSKA, 2023, 57 (06) : 1109 - 1126
[36] Observational studies on pharmacological treatment for manic episodes and mood stabilization in bipolar disorders
Czekalla, J
PHARMACOPSYCHIATRY, 2005, 38 (05) : 235 - 235
[37] Mood disorders in multiple sclerosis and the effects on cognition
Feinstein, A
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2006, 245 (1-2) : 63 - 66
[38] Using neuroimaging to evaluate and guide pharmacological and psychotherapeutic treatments for mood disorders in children
Singh, Manpreet K.
Garrett, Amy S.
Chang, Kiki D.
CNS SPECTRUMS, 2015, 20 (04) : 359 - 368
[39] PHARMACOLOGICAL EFFECTS OF BERBERINE ON THE LONGITUDINAL MUSCLE OF THE GUINEA-PIG ISOLATED ILEUM
TSAI, CS
OCHILLO, RF
ARCHIVES INTERNATIONALES DE PHARMACODYNAMIE ET DE THERAPIE, 1991, 310 : 116 - 131
[40] Comorbidity of bipolar mood disorders and unipolar mood disorders with personality disorders
Rossi, A
Marinangeli, MG
EUROPEAN PSYCHIATRY, 2000, 15 : 366S - 366S

← 1 2 3 4 5 →